These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15683474)

  • 1. Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise.
    Boriani G; Fallani F; Martignani C; Biffi M; Saporito D; Greco C; Ziacchi M; Levorato M; Pontone G; Valzania C; Diemberger I; Franchi R; Branzi A
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S11-4. PubMed ID: 15683474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right ventricular systolic function and cardiac resynchronization therapy.
    Burri H; Domenichini G; Sunthorn H; Fleury E; Stettler C; Foulkes I; Shah D
    Europace; 2010 Mar; 12(3):389-94. PubMed ID: 19966321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of left ventricular volumes in severe congestive heart failure patients treated by optimized AV sequential left ventricular pacing alone--a 3-dimensional echocardiographic study.
    Butter C; Wellnhofer E; Seifert M; Schlegl M; Hoersch W; Goehring A; Fleck E
    Am Heart J; 2006 Jan; 151(1):115-23. PubMed ID: 16368302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
    Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
    Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy.
    Valzania C; Fallani F; Gavaruzzi G; Biffi M; Martignani C; Diemberger I; Bertini M; Domenichini G; Ziacchi M; Gadler F; Eriksson MJ; Braunschweig F; Franchi R; Branzi A; Rapezzi C; Boriani G
    Am J Cardiol; 2010 Aug; 106(3):389-94. PubMed ID: 20643252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices.
    Horwich T; Foster E; De Marco T; Tseng Z; Saxon L
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1284-9. PubMed ID: 15574179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy.
    Bleeker GB; Schalij MJ; Nihoyannopoulos P; Steendijk P; Molhoek SG; van Erven L; Bootsma M; Holman ER; van der Wall EE; Bax JJ
    J Am Coll Cardiol; 2005 Dec; 46(12):2264-9. PubMed ID: 16360056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy (CRT) with right ventricular sense triggered left ventricular pacing benefits for the hemodynamics compared with standard CRT for chronic congestive heart failure: A cross-over study.
    Pu LJ; Wang Y; Zhao L; Luo ZL; Hua BT; Han MH; Li SM; Yang J; Li L; Peng YZ; Guo T
    Cardiol J; 2015; 22(1):80-6. PubMed ID: 25179313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.
    Knappe D; Pouleur AC; Shah AM; Bourgoun M; Brown MW; Foster E; Pfeffer MA; Moss AJ; Solomon SD;
    J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.
    Madaric J; Vanderheyden M; Van Laethem C; Verhamme K; Feys A; Goethals M; Verstreken S; Geelen P; Penicka M; De Bruyne B; Bartunek J
    Eur Heart J; 2007 Sep; 28(17):2134-41. PubMed ID: 17504802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cardiac resynchronization therapy on right ventricular function during rest and exercise, as assessed by radionuclide angiography, and on NT-proBNP levels.
    Valzania C; Biffi M; Bonfiglioli R; Fallani F; Martignani C; Diemberger I; Ziacchi M; Frisoni J; Tomasi L; Fanti S; Rapezzi C; Boriani G
    J Nucl Cardiol; 2019 Feb; 26(1):123-132. PubMed ID: 28667454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography.
    Boriani G; Valzania C; Fallani F; Biffi M; Martignani C; Saporito D; Ziacchi M; Diemberger I; Greco C; Bertini M; Domenichini G; Levorato M; Franchi R; Branzi A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S43-6. PubMed ID: 17302715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segmental wall motion abnormality analyzed by equilibrium radionuclide angiography and improvement in ventricular function by cardiac resynchronization therapy.
    Eder V; Fauchier L; Courtehoux M; Bonnet P; Babuty D
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S58-61. PubMed ID: 17302719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
    Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
    J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
    Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure.
    Yu CM; Fung JW; Chan CK; Chan YS; Zhang Q; Lin H; Yip GW; Kum LC; Kong SL; Zhang Y; Sanderson JE
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1058-65. PubMed ID: 15363081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.